A study with Citrobacter rodentium, a murine model for pathogenic E. coli infection, showed the beneficial effect of IL4 treatments for mucosal healing by affecting mucus production, pathogen adhesion, and colitis [77]. Here, IL4 is linked to escherichia coli infection.